Form 8-K - Current report:
SEC Accession No. 0001104659-25-065926
Filing Date
2025-07-07
Accepted
2025-07-07 06:06:11
Documents
45
Period of Report
2025-07-07
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2519512d2_8k.htm   iXBRL 8-K 43291
2 EXHIBIT 99.1 tm2519512d2_ex99-1.htm EX-99.1 26790
3 EXHIBIT 99.2 tm2519512d2_ex99-2.htm EX-99.2 49832
7 GRAPHIC tm2519512d2_ex99-1img001.jpg GRAPHIC 26357
8 GRAPHIC tm2519512d2_ex99-2img001.jpg GRAPHIC 123806
9 GRAPHIC tm2519512d2_ex99-2img002.jpg GRAPHIC 466083
10 GRAPHIC tm2519512d2_ex99-2img003.jpg GRAPHIC 145442
11 GRAPHIC tm2519512d2_ex99-2img004.jpg GRAPHIC 68531
12 GRAPHIC tm2519512d2_ex99-2img005.jpg GRAPHIC 224316
13 GRAPHIC tm2519512d2_ex99-2img006.jpg GRAPHIC 192865
14 GRAPHIC tm2519512d2_ex99-2img007.jpg GRAPHIC 177976
15 GRAPHIC tm2519512d2_ex99-2img008.jpg GRAPHIC 190035
16 GRAPHIC tm2519512d2_ex99-2img009.jpg GRAPHIC 82839
17 GRAPHIC tm2519512d2_ex99-2img010.jpg GRAPHIC 159053
18 GRAPHIC tm2519512d2_ex99-2img011.jpg GRAPHIC 156813
19 GRAPHIC tm2519512d2_ex99-2img012.jpg GRAPHIC 161542
20 GRAPHIC tm2519512d2_ex99-2img013.jpg GRAPHIC 129539
21 GRAPHIC tm2519512d2_ex99-2img014.jpg GRAPHIC 135189
22 GRAPHIC tm2519512d2_ex99-2img015.jpg GRAPHIC 195682
23 GRAPHIC tm2519512d2_ex99-2img016.jpg GRAPHIC 171538
24 GRAPHIC tm2519512d2_ex99-2img017.jpg GRAPHIC 152799
25 GRAPHIC tm2519512d2_ex99-2img018.jpg GRAPHIC 162077
26 GRAPHIC tm2519512d2_ex99-2img019.jpg GRAPHIC 175681
27 GRAPHIC tm2519512d2_ex99-2img020.jpg GRAPHIC 167482
28 GRAPHIC tm2519512d2_ex99-2img021.jpg GRAPHIC 205533
29 GRAPHIC tm2519512d2_ex99-2img022.jpg GRAPHIC 94046
30 GRAPHIC tm2519512d2_ex99-2img023.jpg GRAPHIC 160774
31 GRAPHIC tm2519512d2_ex99-2img024.jpg GRAPHIC 147287
32 GRAPHIC tm2519512d2_ex99-2img025.jpg GRAPHIC 154369
33 GRAPHIC tm2519512d2_ex99-2img026.jpg GRAPHIC 86719
34 GRAPHIC tm2519512d2_ex99-2img027.jpg GRAPHIC 181574
35 GRAPHIC tm2519512d2_ex99-2img028.jpg GRAPHIC 185243
36 GRAPHIC tm2519512d2_ex99-2img029.jpg GRAPHIC 235375
37 GRAPHIC tm2519512d2_ex99-2img030.jpg GRAPHIC 277971
  Complete submission text file 0001104659-25-065926.txt   7475297

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA apge-20250707.xsd EX-101.SCH 3044
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE apge-20250707_lab.xml EX-101.LAB 34239
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apge-20250707_pre.xml EX-101.PRE 22378
47 EXTRACTED XBRL INSTANCE DOCUMENT tm2519512d2_8k_htm.xml XML 3815
Mailing Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453 650-394-5230
Apogee Therapeutics, Inc. (Filer) CIK: 0001974640 (see all company filings)

EIN.: 934958665 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41740 | Film No.: 251106914
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)